J&J Defends Talc Powder As 1st Post-Spinoff Trial Begins
Johnson & Johnson on Wednesday began its first talc trial since the spinoff and bankruptcy of its talc business, defending against a terminal mesothelioma patient's claims that the company has sought...To view the full article, register now.
Already a subscriber? Click here to view full article